SBIR/STTR Research Award
AN IN VIVO DETECTOR FOR RADIOLABELED COMPOUNDS
Award amount
$99,955Program and phase
SBIR · Phase IAward year
2002Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SICEL TECHNOLOGIES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Sicel Technologies is creating medical devices for use in diagnostic studies of cancer. The Company's long-term goal is to provide implantable sensors that provide acute and chronic feedback to clinicians during radiation therapy, chemotherapy, and newer immunospecific modalities. The work outlined in this proposal focuses on the development of a detection system to allow for in vivo, time-dependent measurements of radiolabeled compounds. The potential of this measurement capability is in establishing the pharmacokinetic properties of targeted chemotherapeutic agents on an individualized basis.
Technology keywords
Not reported